ViiV Healthcare (Spain)

Recent papers from ViiV Healthcare (Spain)

1. Real‐world use and effectiveness of fostemsavir in a US clinical setting: Insights from Trio Health HIV Research NetworkHIV Medicine · 2026
2. Preferences of people living with HIV for treatment regimen attributes: a qualitative interview studyFrontiers in Public Health · 2026
3. ARMED: an Australian cohort retrospective observational study to understand motivations for switching and clinical outcomes of individuals switching to dolutegravir/lamivudineSexual Health · 2026
4. Clinical outcomes of a digitally delivered structured lifestyle program in type 2 diabetes: a randomized controlled trial from IndiaFrontiers in Endocrinology · 2026
5. Similar Efficacy, Safety, and Immune Improvement Through 96 Weeks in Individuals With Limited HIV-1 Treatment Options Using Twice-Daily Dolutegravir- or Fostemsavir-based RegimensOpen Forum Infectious Diseases · 2026
6. Investing in enhanced HIV prevention among young men who have sex with men in Brazil: insights from fiscal health modelingJournal of Medical Economics · 2026
7. Evaluation of Real-World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir/Lamivudine Fixed-Dose Combination in Treatment-Naive and Pretreated People Living With HIV Who are Virologically Suppressed, in Routine Clinical Care in France: Results From the CARAVEL StudyOpen Forum Infectious Diseases · 2026
8. Design and methods of the “Understanding pre-exposure prophylaxis modalities for HIV prevention in European communities” (PROTECT) survey - exploring the sexual health of men who have sex with men, trans and non-binary peopleHeliyon · 2026
9. Broad reactivity of HLA-E restricted TCRs highlights challenges in universal T cell therapy development 2335164The Journal of Immunology · 2026
10. VOGUE: Non-Inferior Efficacy of Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide in Adults With HIV-1 Naive to TreatmentOpen Forum Infectious Diseases · 2026
11. The burden of HIV-related stigma on clinical and quality of life outcomes: results from a systematic literature reviewHealth Psychology and Behavioral Medicine · 2026
12. Long-Acting Cabotegravir Injections Are More Acceptable Than Long-Acting Lenacapavir Injections After One Dose: Results From the CLARITY Randomized Crossover StudyAdvances in Therapy · 2026
13. Real-World Safety and Effectiveness of Cabotegravir in People Living with HIV: Interim Report of a Post-marketing Surveillance in JapanAdvances in Therapy · 2026
14. Effect of manufacturing method on metal ion release from orthodontic brackets and tubesScientific Reports · 2026
15. Implementation Journey with CAB LA for PrEP Among Men Who Have Sex with Men and Transgender Men: Insights from the PILLAR Trial Through 12 MonthsAIDS and Behavior · 2026
16. CD4+ cell count trends after common cancers in people with HIV: a multicohort collaborationAIDS · 2026
17. Wearable-derived cardiovascular fitness age and its lifestyle correlates in 442 adultsFrontiers in Digital Health · 2026
18. Advancing the inclusion of pregnant and lactating populations in HIV PrEP research: ethical, regulatory, and surveillance recommendations from a multisectoral working groupFrontiers in Public Health · 2026
19. Extended PrEP cascades and determinants of long-acting PrEP intention and unmet PrEP needs among transgender women, transgender men, and non-binary individuals in 20 European countriesInternational Journal of Transgender Health · 2026
20. A New Definition of Major TraumaAnnals of Surgery · 2026